Enliven Therapeutics shared on LinkedIn:
“We’re grateful to The Max Foundation for its efforts to improve access to cancer treatment worldwide.
We were honored to welcome Pat Garcia-Gonzalez, CEO of The Max Foundation, to our recent company offsite to share more about Max’s work and the patients it serves. Pat’s presentation reinforced the importance of keeping patients at the center of everything we do.
Through efforts to expand access to diagnostic testing, treatment and ongoing patient support, the Max is helping make cancer care more accessible for people living with CML and other cancers in underserved communities.
We’re grateful for the opportunity to collaborate with an organization so deeply committed to improving the lives of patients and their families.”
About The Max Foundation
The Max Foundation is a global nonprofit organization founded in 1997 that works to improve access to cancer treatment for patients in underserved communities, particularly in low- and middle-income countries.
The organization helps patients access life-extending medicines, diagnostic testing, and ongoing support services, with a strong focus on cancers such as chronic myeloid leukemia (CML).
It also works with pharmaceutical companies, healthcare professionals, and local organizations to reduce barriers to cancer care.
You may also be interested in:
The Max Foundation Highlights Improved Treatment Access for PNH Patients in Nepal